150 related articles for article (PubMed ID: 23391298)
41. Juvenile Kearns-Sayre syndrome initially misdiagnosed as a psychosomatic disorder.
Nørby S; Lestienne P; Nelson I; Nielsen IM; Schmalbruch H; Sjö O; Warburg M
J Med Genet; 1994 Jan; 31(1):45-50. PubMed ID: 8151637
[TBL] [Abstract][Full Text] [Related]
42. MELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathy.
Ohno K; Yamamoto M; Engel AG; Harper CM; Roberts LR; Tan GH; Fatourechi V
Ann Neurol; 1996 Jun; 39(6):761-6. PubMed ID: 8651648
[TBL] [Abstract][Full Text] [Related]
43. Quantification of mitochondrial DNA in heteroplasmic fibroblasts with competitive PCR.
Wang H; Fliegel L; Cass CE; Penn AM; Michalak M; Weiner JH; Lemire BD
Biotechniques; 1994 Jul; 17(1):76-8, 80, 82. PubMed ID: 7946321
[TBL] [Abstract][Full Text] [Related]
44. Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome.
Poulton J; O'Rahilly S; Morten KJ; Clark A
Diabetologia; 1995 Jul; 38(7):868-71. PubMed ID: 7556992
[TBL] [Abstract][Full Text] [Related]
45. Unusual clinical presentation of a patient carrying a novel single 1.8 kb deletion of mitochondrial DNA.
Zoccolella S; Torraco A; Amati A; Lamberti P; Serlenga L; Papa S; Petruzzella V
Funct Neurol; 2006; 21(1):39-41. PubMed ID: 16735000
[TBL] [Abstract][Full Text] [Related]
46. The neurological evolution of Pearson syndrome: case report and literature review.
Lee HF; Lee HJ; Chi CS; Tsai CR; Chang TK; Wang CJ
Eur J Paediatr Neurol; 2007 Jul; 11(4):208-14. PubMed ID: 17434771
[TBL] [Abstract][Full Text] [Related]
47. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies.
Zeviani M; Gellera C; Pannacci M; Uziel G; Prelle A; Servidei S; DiDonato S
Ann Neurol; 1990 Jul; 28(1):94-7. PubMed ID: 2375642
[TBL] [Abstract][Full Text] [Related]
48. Mitochondrial DNA deletion in human oocytes and embryos.
Brenner CA; Wolny YM; Barritt JA; Matt DW; Munné S; Cohen J
Mol Hum Reprod; 1998 Sep; 4(9):887-92. PubMed ID: 9783850
[TBL] [Abstract][Full Text] [Related]
49. Progression in a case of Kearns-Sayre syndrome.
Ishikawa Y; Goto Y; Ishikawa Y; Minami R
J Child Neurol; 2000 Nov; 15(11):750-5. PubMed ID: 11108509
[TBL] [Abstract][Full Text] [Related]
50. [Detection of deletions in platelet mitochondrial DNA in Kearns-Sayre syndrome using polymerase chain reaction].
Ota Y; Awaya S; Tanaka M; Sato W; Ohno K; Yamamoto T; Ozawa T; Ota I
Nippon Ganka Gakkai Zasshi; 1991 Aug; 95(8):776-82. PubMed ID: 1950835
[TBL] [Abstract][Full Text] [Related]
51. [Disorders of mitochondrial energy metabolism in patients with the Kearns-Sayre syndrome].
Capková M; Tesarová M; Wenchich L; Cerná L; Hansíková H; Hůlková H; Hrubá E; Elleder M; Zeman J
Cas Lek Cesk; 2002 Feb; 141(2):51-4. PubMed ID: 11925663
[TBL] [Abstract][Full Text] [Related]
52. Ocular myopathy and mitochondrial DNA deletion. A presentation of seven identified Danish patients.
Magalhães PJ; Sjö O; Nørby S
Acta Ophthalmol Scand Suppl; 1996; (219):29-32. PubMed ID: 8741113
[TBL] [Abstract][Full Text] [Related]
53. A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up.
Mohri I; Taniike M; Fujimura H; Matsuoka T; Inui K; Nagai T; Okada S
J Neurol Sci; 1998 Jun; 158(1):106-9. PubMed ID: 9667787
[TBL] [Abstract][Full Text] [Related]
54. The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy.
Maceluch JA; Niedziela M
Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):117-37. PubMed ID: 17342029
[TBL] [Abstract][Full Text] [Related]
55. [Retinitis pigmentosa in Kearns-Sayre syndrome resulting from mutation of mitochondrial DNA "de novo"].
Midro AT; Zalewska R; Skrzypczak-Adamiak G; Wilichowski E
Klin Oczna; 1995 Jun; 97(6):203-6. PubMed ID: 7643565
[TBL] [Abstract][Full Text] [Related]
56. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome.
Rötig A; Bourgeron T; Chretien D; Rustin P; Munnich A
Hum Mol Genet; 1995 Aug; 4(8):1327-30. PubMed ID: 7581370
[TBL] [Abstract][Full Text] [Related]
57. Kearns-Sayre syndrome with a phenocopy of choroideremia instead of pigmentary retinopathy.
Herzberg NH; van Schooneveld MJ; Bleeker-Wagemakers EM; Zwart R; Cremers FP; van der Knaap MS; Bolhuis PA; de Visser M
Neurology; 1993 Jan; 43(1):218-21. PubMed ID: 8423892
[TBL] [Abstract][Full Text] [Related]
58. Cardiac transplantation in an incomplete Kearns-Sayre syndrome with mitochondrial DNA deletion.
Tranchant C; Mousson B; Mohr M; Dumoulin R; Welsch M; Weess C; Stepien G; Warter JM
Neuromuscul Disord; 1993; 3(5-6):561-6. PubMed ID: 8186712
[TBL] [Abstract][Full Text] [Related]
59. Molecular instability in the COII-tRNA(Lys) intergenic region of the human mitochondrial genome: multiple origins of the 9-bp deletion and heteroplasmy for expanded repeats.
Thomas MG; Cook CE; Miller KW; Waring MJ; Hagelberg E
Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1371):955-65. PubMed ID: 9684291
[TBL] [Abstract][Full Text] [Related]
60. CPEO and KSS differ in the percentage and location of the mtDNA deletion.
López-Gallardo E; López-Pérez MJ; Montoya J; Ruiz-Pesini E
Mitochondrion; 2009 Sep; 9(5):314-7. PubMed ID: 19410662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
